Researchers say it can Immunotherapywhich is administered intravenously in addition to chemotherapy And before resorting to surgical treatment, it leads to the disappearance of any detectable tumors.
The drug reduces the chances of the disease progressing in the body by 40 percent.
The National Institute for Healthcare and Welfare Excellence, one of the entities affiliated with the Public Health Authority in Great BritainApproval of the drug to be administered to patients with triple negative breast cancer, due to the risk of cancer recurrence after the end of treatment.
Expert Helen Knight says: "The prognosis for triple negative breast cancer is relatively poor and there are few effective treatments compared to other types of the disease".
considered that Medicinal The new treatment helps address needs not covered by previous treatments and gives thousands of women hope of a longer and better life.
Triple negative breast cancer accounts for about 15% of all breast cancer cases and is more common Women under forty.
It reduces the chances of this returning cancer to the body after treatment and prevents it from spreading throughout the body.
“>
And the British newspaper “Daily Mail” reported that the new drug, “pembrolizumab” is intended to fight Triple negative breast cancerIt is responsible for one in four deaths from disease breast cancer generally.
Researchers say it can Immunotherapywhich is administered intravenously in addition to chemotherapy And before resorting to surgical treatment, it leads to the disappearance of any detectable tumors.
The drug reduces the chances of the disease progressing in the body by 40 percent.
The National Institute for Healthcare and Welfare Excellence, one of the entities affiliated with the Public Health Authority in Great BritainApproval of the drug to be administered to patients with triple negative breast cancer, due to the risk of cancer recurrence after the end of treatment.
“The prognosis for triple negative breast cancer is relatively poor and there are few effective treatments compared to other types of the disease,” says expert Helen Knight.
considered that Medicinal The new treatment helps address needs not covered by previous treatments and gives thousands of women hope of a longer and better life.
Triple negative breast cancer accounts for about 15% of all breast cancer cases and is more common Women under forty.
It reduces the chances of this returning cancer to the body after treatment and prevents it from spreading throughout the body.
